Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.

Hans-Joachim Schmoll; Lars H Lindner; Peter Reichardt; Klaus Heißner; Hans-Georg Kopp; Torsten Kessler; Regine Mayer-Steinacker; Jörn Rüssel; Gerlinde Egerer; Martina Crysandt; Bernd Kasper; Dietger Niederwieser; Annegret Kunitz; Ekkehard Eigendorff; Iver Petersen; Jörg Steighardt; Franziska Cygon; Fabian Meinert; Alexander Stein

doi:10.1001/jamaoncol.2020.6564

Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.

Hans-Joachim Schmoll, Lars H Lindner, Peter Reichardt, Klaus Heißner (Co-author), Hans-Georg Kopp, Torsten Kessler, Regine Mayer-Steinacker, Jörn Rüssel, Gerlinde Egerer, Martina Crysandt, Bernd Kasper, Dietger Niederwieser, Annegret Kunitz, Ekkehard Eigendorff, Iver Petersen, Jörg Steighardt, Franziska Cygon, Fabian Meinert, Alexander Stein

Department of Internal Medicine III, Division of Respiratory Medicine, Allergology and Sleep Medicine

Research output: Contribution to journal › Original Article › peer-review

24 Citations (Web of Science)

Original language	English
Pages (from-to)	255-262
Journal	JAMA ONCOLOGY
Volume	7
Issue number	2
DOIs	https://doi.org/10.1001/jamaoncol.2020.6564
Publication status	Published - 2021

Keywords

II TRIAL
LEIOMYOSARCOMAS
CHEMOTHERAPY
MULTICENTER
DOCETAXEL
EORTC

Access to Document

10.1001/jamaoncol.2020.6564

Cite this

Schmoll, H.-J., Lindner, L. H., Reichardt, P., Heißner, K., Kopp, H.-G., Kessler, T., Mayer-Steinacker, R., Rüssel, J., Egerer, G., Crysandt, M., Kasper, B., Niederwieser, D., Kunitz, A., Eigendorff, E., Petersen, I., Steighardt, J., Cygon, F., Meinert, F., & Stein, A. (2021). Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial. JAMA ONCOLOGY, 7(2), 255-262. https://doi.org/10.1001/jamaoncol.2020.6564

@article{55f4f8ea23534236b6e1399a6e16a800,

title = "Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.",

keywords = "II TRIAL, LEIOMYOSARCOMAS, CHEMOTHERAPY, MULTICENTER, DOCETAXEL, EORTC",

author = "Hans-Joachim Schmoll and Lindner, {Lars H} and Peter Reichardt and Klaus Hei{\ss}ner and Hans-Georg Kopp and Torsten Kessler and Regine Mayer-Steinacker and J{\"o}rn R{\"u}ssel and Gerlinde Egerer and Martina Crysandt and Bernd Kasper and Dietger Niederwieser and Annegret Kunitz and Ekkehard Eigendorff and Iver Petersen and J{\"o}rg Steighardt and Franziska Cygon and Fabian Meinert and Alexander Stein",

note = "Hei{\ss}ner: Paracelsus Medical University, Nuremberg, Germany.",

year = "2021",

doi = "10.1001/jamaoncol.2020.6564",

language = "English",

volume = "7",

pages = "255--262",

journal = "JAMA ONCOLOGY",

issn = "2374-2437",

number = "2",

}

Schmoll, H-J, Lindner, LH, Reichardt, P, Heißner, K, Kopp, H-G, Kessler, T, Mayer-Steinacker, R, Rüssel, J, Egerer, G, Crysandt, M, Kasper, B, Niederwieser, D, Kunitz, A, Eigendorff, E, Petersen, I, Steighardt, J, Cygon, F, Meinert, F & Stein, A 2021, 'Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.', JAMA ONCOLOGY, vol. 7, no. 2, pp. 255-262. https://doi.org/10.1001/jamaoncol.2020.6564

Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial. / Schmoll, Hans-Joachim; Lindner, Lars H; Reichardt, Peter et al.
In: JAMA ONCOLOGY, Vol. 7, No. 2, 2021, p. 255-262.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.

AU - Schmoll, Hans-Joachim

AU - Lindner, Lars H

AU - Reichardt, Peter

AU - Heißner, Klaus

AU - Kopp, Hans-Georg

AU - Kessler, Torsten

AU - Mayer-Steinacker, Regine

AU - Rüssel, Jörn

AU - Egerer, Gerlinde

AU - Crysandt, Martina

AU - Kasper, Bernd

AU - Niederwieser, Dietger

AU - Kunitz, Annegret

AU - Eigendorff, Ekkehard

AU - Petersen, Iver

AU - Steighardt, Jörg

AU - Cygon, Franziska

AU - Meinert, Fabian

AU - Stein, Alexander

N1 - Heißner: Paracelsus Medical University, Nuremberg, Germany.

PY - 2021

Y1 - 2021

KW - II TRIAL

KW - LEIOMYOSARCOMAS

KW - CHEMOTHERAPY

KW - MULTICENTER

KW - DOCETAXEL

KW - EORTC

U2 - 10.1001/jamaoncol.2020.6564

DO - 10.1001/jamaoncol.2020.6564

M3 - Original Article

C2 - 33355646

SN - 2374-2437

VL - 7

SP - 255

EP - 262

JO - JAMA ONCOLOGY

JF - JAMA ONCOLOGY

IS - 2

ER -